Articles |
the Division of Basic Sciences, Department of Medicine, University of Crete, and Institute of Molecular Biology and Biotechnology, FORTH, Heraklion, Crete, Greece (D.K., I. Talianidis, V.Z.), and the Section of Molecular Genetics, Center for Advanced Biomedical Research, Boston (Mass) University Medical Center (I. Tzameli, M.H.-C., V.Z.).
Correspondence to Vassilis Zannis, Division of Basic Sciences, Department of Medicine, University of Crete, and IMBB, FORTH, Heraklion, Crete, Greece.
Transient transfection assays have shown that the distal apoC-III promoter segments that contain the regulatory elements F to J enhance the strength of the tandemly linked proximal apoA-I promoter 5- to 13-fold in hepatic (HepG2) cells. Activation in intestinal (CaCo-2) cells to levels comparable to those obtained in HepG2 cells requires a larger apoA-I promoter sequence that extends to nucleotide -1500 as well as the presence of hepatic nuclear factor-4 (HNF-4). The distal apoC-III regulatory elements can also enhance 4- to 8-fold the strength of the heterologous apoB promoter in HepG2 and CaCo-2 cells. Finally, these elements in the presence of HNF-4 enhance 14.5- to 18.5-fold the strength of the minimal adenovirus major late promoter linked to two copies of the hormone response element (HRE) AID of apoA-I in both HepG2 and CaCo-2 cells. In vitro mutagenesis of the promoter/enhancer cluster established that the enhancer activity is lost by a mutation in the HRE present in the 3' end of the regulatory element I (-736 to -714) and is reduced significantly by point mutations or deletions in one or more of the regulatory elements F to J of the apoC-III enhancer. The enhancer activity also requires the HREs of the proximal apoA-I promoter. The apoC-III enhancer can also restore the activity of the proximal apoA-I and apoB promoters that have been inactivated by mutations in CCAAT/enhancer binding protein binding sites, indicating that C/EBP may not participate in the synergistic activation of the promoter/enhancer cluster. The findings suggest that the regulatory elements F to J of the apoC-III promoter act as a general modular enhancer that can potentiate the strength of proximal promoters that contain HREs. Such potentiation in the HepG2 cells can be accounted for by synergistic interactions between HNF-4 or other nuclear hormone receptors bound to the proximal and distal HREs and SP1 or other factors bound to the apoC-III enhancer. Additional factors may be required for optimal activity in CaCo-2 cells as well as for the function of this region as an intestinal enhancer.
Key Words: apoC-III enhancer transcriptional synergism hepatic and intestinal expression apoA-I gene regulation hepatic nuclear factor-4 (HNF-4)
This article has been cited by other articles:
![]() |
E. Grenier, F. S. Maupas, J.-F. Beaulieu, E. Seidman, E. Delvin, A. Sane, E. Tremblay, C. Garofalo, and E. Levy Effect of retinoic acid on cell proliferation and differentiation as well as on lipid synthesis, lipoprotein secretion, and apolipoprotein biogenesis Am J Physiol Gastrointest Liver Physiol, December 1, 2007; 293(6): G1178 - G1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Benoit, A. Cooney, V. Giguere, H. Ingraham, M. Lazar, G. Muscat, T. Perlmann, J.-P. Renaud, J. Schwabe, F. Sladek, et al. International Union of Pharmacology. LXVI. Orphan Nuclear Receptors Pharmacol. Rev., December 1, 2006; 58(4): 798 - 836. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Archer, D. Sauvaget, V. Chauffeton, P.-E. Bouchet, J. Chambaz, M. Pincon-Raymond, P. Cardot, A. Ribeiro, and M. Lacasa Intestinal Apolipoprotein A-IV Gene Transcription Is Controlled by Two Hormone-Responsive Elements: A Role for Hepatic Nuclear Factor-4 Isoforms Mol. Endocrinol., September 1, 2005; 19(9): 2320 - 2334. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Aggelidou, P. Iordanidou, P. Tsantili, G. Papadopoulos, and M. Hadzopoulou-Cladaras Critical Role of Residues Defining the Ligand Binding Pocket in Hepatocyte Nuclear Factor-4{alpha} J. Biol. Chem., July 16, 2004; 279(29): 30680 - 30688. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-f. Wang, X. Liu, J. O'Connell, Z. Peng, R. M. Krauss, D. L. Rainwater, J. L. VandeBerg, Edward. M. Rubin, J.-F. Cheng, and L. A. Pennacchio Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons Hum. Mol. Genet., May 15, 2004; 13(10): 1049 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sauvaget, V. Chauffeton, D. Citadelle, F.-P. Chatelet, C. Cywiner-Golenzer, J. Chambaz, M. Pincon-Raymond, P. Cardot, J. Le Beyec, and A. Ribeiro Restriction of Apolipoprotein A-IV Gene Expression to the Intestine Villus Depends on a Hormone-responsive Element and Parallels Differential Expression of the Hepatic Nuclear Factor 4alpha and gamma Isoforms J. Biol. Chem., September 6, 2002; 277(37): 34540 - 34548. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pastier, J.-M. Lacorte, J. Chambaz, P. Cardot, and A. Ribeiro Two Initiator-like Elements Are Required for the Combined Activation of the Human Apolipoprotein C-III Promoter by Upstream Stimulatory Factor and Hepatic Nuclear Factor-4 J. Biol. Chem., April 19, 2002; 277(17): 15199 - 15206. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eeckhoute, P. Formstecher, and B. Laine Maturity-Onset Diabetes of the Young Type 1 (MODY1)-Associated Mutations R154X and E276Q in Hepatocyte Nuclear Factor 4{{alpha}} (HNF4{{alpha}}) Gene Impair Recruitment of p300, a Key Transcriptional Coactivator Mol. Endocrinol., July 1, 2001; 15(7): 1200 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Georgopoulos, H.-Y. Kan, C. Reardon-Alulis, and V. Zannis The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice Nucleic Acids Res., December 15, 2000; 28(24): 4919 - 4929. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Ning, and S. A. Duncan Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha Genes & Dev., February 15, 2000; 14(4): 464 - 474. [Abstract] [Full Text] |
||||
![]() |
H. Dell and M. Hadzopoulou-Cladaras CREB-binding Protein Is a Transcriptional Coactivator for Hepatocyte Nuclear Factor-4 and Enhances Apolipoprotein Gene Expression J. Biol. Chem., March 26, 1999; 274(13): 9013 - 9021. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Le Beyec, V. Chauffeton, H.-Y. Kan, P.-L. Janvier, C. Cywiner-Golenzer, F.-P. Chatelet, A. D. Kalopissis, V. Zannis, J. Chambaz, M. Pincon-Raymond, et al. The -700/-310 Fragment of the Apolipoprotein A-IV Gene Combined with the -890/-500 Apolipoprotein C-III Enhancer Is Sufficient to Direct a Pattern of Gene Expression Similar to That for the Endogenous Apolipoprotein A-IV Gene J. Biol. Chem., February 19, 1999; 274(8): 4954 - 4961. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Moustakas and D. Kardassis Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members PNAS, June 9, 1998; 95(12): 6733 - 6738. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vorgia, V. I. Zannis, and D. Kardassis A Short Proximal Promoter and the Distal Hepatic Control Region-1 (HCR-1) Contribute to the Liver Specificity of the Human Apolipoprotein C-II Gene. HEPATIC ENHANCEMENT BY HCR-1 REQUIRES TWO PROXIMAL HORMONE RESPONSE ELEMENTS WHICH HAVE DIFFERENT BINDING SPECIFICITIES FOR ORPHAN RECEPTORS HNF-4, ARP-1, and EAR-2 J. Biol. Chem., February 13, 1998; 273(7): 4188 - 4196. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Wade, L. H. Puckey, B. L. Knight, F. Acquati, A. Mihalich, and R. Taramelli Characterization of Multiple Enhancer Regions Upstream of the Apolipoprotein(a) Gene J. Biol. Chem., November 28, 1997; 272(48): 30387 - 30399. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Kan, S. Georgopoulos, and V. Zannis A Hormone Response Element in the Human Apolipoprotein CIII (ApoCIII) Enhancer Is Essential for Intestinal Expression of the ApoA-I and ApoCIII Genes and Contributes to the Hepatic Expression of the Two Linked Genes in Transgenic Mice J. Biol. Chem., September 22, 2000; 275(39): 30423 - 30431. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kardassis, K. Pardali, and V. I. Zannis SMAD Proteins Transactivate the Human ApoCIII Promoter by Interacting Physically and Functionally with Hepatocyte Nuclear Factor 4 J. Biol. Chem., December 22, 2000; 275(52): 41405 - 41414. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |